<DOC>
	<DOCNO>NCT01179477</DOCNO>
	<brief_summary>The purpose multicenter post-approval study evaluate acute chronic performance QuickFlex® μ 1258T leave ventricular lead .</brief_summary>
	<brief_title>QuickFlex Micro Left Ventricular Lead Post Approval Study</brief_title>
	<detailed_description>The endpoint study : - Complication free survival rate 5 year complication related LV lead - Electrical performance ( capture threshold ) St. Jude Medical 's QuickFlex®µ 1258T LV Lead</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Menthol</mesh_term>
	<criteria>Have approve indication per ACC/AHA/HRS guideline implantation CRTD system participate QuickFlex® μ1258T IDE study Have ability provide inform consent study participation willing able comply prescribe followup test schedule evaluation Have hypersensitivity single 1.0mg dose dexamethasone sodium phosphate short term contact heparin Have life expectancy le 5 year due condition Be le 18 year age</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Left heart pace lead</keyword>
	<keyword>Cardiac resynchronization therapy ( CRT )</keyword>
	<keyword>Heart failure</keyword>
</DOC>